Barclays PLC Xeris Biopharma Holdings, Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 424,248 shares of XERS stock, worth $4.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

424,248

Previous 424,248 -0.0%

Holding current value

$4.14 Million

Previous $1.98 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$3.95 - $5.16 $567,271 - $741,043	143,613 Added 51.17%	424,248 $1.98 Million
Q1 2025 May 15, 2025	SELL	$3.2 - $5.95 $214,422 - $398,691	-67,007 Reduced 19.27%	280,635 $1.54 Million
Q4 2024 Feb 13, 2025	BUY	$2.78 - $3.73 $64,412 - $86,424	23,170 Added 7.14%	347,642 $1.18 Million
Q3 2024 Nov 15, 2024	BUY	$2.06 - $2.96 $312,471 - $448,987	151,685 Added 87.79%	324,472 $925,000
Q2 2024 Aug 14, 2024	SELL	$1.7 - $2.45 $54,716 - $78,855	-32,186 Reduced 15.7%	172,787 $389,000
Q1 2024 May 15, 2024	SELL	$2.04 - $3.22 $144,819 - $228,587	-70,990 Reduced 25.72%	204,973 $453,000
Q4 2023 Feb 15, 2024	BUY	$1.47 - $2.36 $250,223 - $401,719	170,220 Added 160.98%	275,963 $648,000
Q3 2023 Nov 07, 2023	BUY	$1.8 - $2.69 $23,472 - $35,077	13,040 Added 14.07%	105,743 $197,000
Q2 2023 Aug 03, 2023	SELL	$1.82 - $2.98 $85,592 - $140,146	-47,029 Reduced 33.66%	92,703 $242,000
Q1 2023 May 04, 2023	BUY	$1.03 - $1.63 $32,363 - $51,216	31,421 Added 29.01%	139,732 $229,000
Q4 2022 Feb 13, 2023	BUY	$1.14 - $1.65 $54,225 - $78,483	47,566 Added 78.3%	108,311 $144,000
Q3 2022 Nov 03, 2022	BUY	$1.37 - $1.93 $42,676 - $60,121	31,151 Added 105.26%	60,745 $95,000
Q2 2022 Aug 12, 2022	BUY	$1.48 - $2.64 $11,552 - $20,607	7,806 Added 35.83%	29,594 $46,000
Q1 2022 May 16, 2022	BUY	$2.0 - $2.87 $43,576 - $62,531	21,788 New	21,788 $56,000

Others Institutions Holding XERS

# of Institutions

215

Shares Held

89.8M

Call Options Held

81.6K

Put Options Held

57.6K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $1.33B
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account